<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36171050</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2052-4439</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>BMJ open respiratory research</Title><ISOAbbreviation>BMJ Open Respir Res</ISOAbbreviation></Journal><ArticleTitle>Early experiences of the Your COVID Recovery<sup>&#xae;</sup> digital programme for individuals with long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e001237</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjresp-2022-001237</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To describe the early data from the Your COVID Recovery<sup>&#xae;</sup> digital programme and to explore the data collected from two embedded outcome measures.</AbstractText><AbstractText Label="DESIGN">Observational.</AbstractText><AbstractText Label="SETTING">Primary and secondary care (England-Online).</AbstractText><AbstractText Label="PARTICIPANTS">110 individuals completed the programme (68.1% female, 88.1% White British, age: 46.3 (10.8) years, weight: 86.5 (21.1) kg, height: 169.3 (10.0) cm). 47.2% of patients reported comorbidities.</AbstractText><AbstractText Label="INTERVENTION">Following an assessment by a healthcare professional, individuals with long COVID were offered access to the Your COVID Recovery<sup>&#xae;</sup> digital programme. The programme comprises of four stages for the participants to progress through. Participants are encouraged to record severity of their symptoms and amount of activity they are doing on a symptom and an activity tracker. Resources and interactive material on managing symptoms of long COVID are available throughout each stage.</AbstractText><AbstractText Label="PRIMARY OUTCOME MEASURES">Questionnaire (EuroQ0l 5-Dimension 5-Level (EQ-5D-5L) and the chronic obstructive pulmonary disease assessment test (CAT)) data were extracted from the site from 11 March 2021 until 9 November 2021.</AbstractText><AbstractText Label="RESULTS">Participants were on the programme for 8.6 (4.3) weeks. There was a statistically significant increase in EQ-5D-5L visual analogue scale (VAS) score (pre=48.8 (19.5); post=59.9 (22.1); p&lt;0.01). The EQ-5D-5L Index Value preintervention to postintervention did improve but not significantly (pre=0.5 (0.3); post=0.6 (0.3); p=0.09). CAT total score improved significantly preintervention to postintervention (pre=19.8 (7.2); post=15.6 (7.6); p&lt;0.01). All CAT item scores significantly improved preintervention to postintervention (p&lt;0.005), except the phlegm item score (p=0.168).</AbstractText><AbstractText Label="DISCUSSION">This early data describes the impact of the Your COVID Recovery<sup>&#xae;</sup> digital programme on the first cohort of patients to complete the digital recovery programme. The outcome data are promising and should encourage uptake.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lloyd-Evans</LastName><ForeName>Phoebe H I</ForeName><Initials>PHI</Initials><Identifier Source="ORCID">0000-0002-1844-0616</Identifier><AffiliationInfo><Affiliation>Centre for Exercise and Rehabilitation Sciences, NIHR Leicester Biomedical Research Centre - Respiratory, University Hospitals of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baldwin</LastName><ForeName>Molly M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Centre for Exercise and Rehabilitation Sciences, NIHR Leicester Biomedical Research Centre - Respiratory, University Hospitals of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daynes</LastName><ForeName>Enya</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for Exercise and Rehabilitation Sciences, NIHR Leicester Biomedical Research Centre - Respiratory, University Hospitals of Leicester, Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Annabel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Exercise and Rehabilitation Sciences, NIHR Leicester Biomedical Research Centre - Respiratory, University Hospitals of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mills</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Exercise and Rehabilitation Sciences, NIHR Leicester Biomedical Research Centre - Respiratory, University Hospitals of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goddard</LastName><ForeName>Amye C N</ForeName><Initials>ACN</Initials><AffiliationInfo><Affiliation>Centre for Exercise and Rehabilitation Sciences, NIHR Leicester Biomedical Research Centre - Respiratory, University Hospitals of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaplin</LastName><ForeName>Emma</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-0981-2980</Identifier><AffiliationInfo><Affiliation>Centre for Exercise and Rehabilitation Sciences, NIHR Leicester Biomedical Research Centre - Respiratory, University Hospitals of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gardiner</LastName><ForeName>Nikki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Centre for Exercise and Rehabilitation Sciences, NIHR Leicester Biomedical Research Centre - Respiratory, University Hospitals of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Sally J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Centre for Exercise and Rehabilitation Sciences, NIHR Leicester Biomedical Research Centre - Respiratory, University Hospitals of Leicester, Leicester, UK sally.singh@uhl-tr.nhs.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Your COVID Recovery&#xae; Development Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open Respir Res</MedlineTA><NlmUniqueID>101638061</NlmUniqueID><ISSNLinking>2052-4439</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>21</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36171050</ArticleId><ArticleId IdType="pmc">PMC9527747</ArticleId><ArticleId IdType="doi">10.1136/bmjresp-2022-001237</ArticleId><ArticleId IdType="pii">9/1/e001237</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stavem K, Ghanima W, Olsen MK, et al. . Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax 2021;76:405&#x2013;7. 10.1136/thoraxjnl-2020-216377</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216377</ArticleId><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EM, et al. . Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med 2021;9:1275&#x2013;87. 10.1016/S2213-2600(21)00383-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Institute for Health and Care Excellence . COVID-19 rapid guideline: managing the long-term effects of COVID-19, 2021. Available: https://www.nice.org.uk/guidance/ng188 [Accessed 15 Nov 2021].</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>
Census . Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK, 2022. Available: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/1june2022 [Accessed 28 Jun 2022].</Citation></Reference><Reference><Citation>Li Jian'an, Xia W, Zhan C, et al. . A telerehabilitation programme in post-discharge COVID-19 patients (TERECO): a randomised controlled trial. Thorax 2022;77:697&#x2013;706. 10.1136/thoraxjnl-2021-217382</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-217382</ArticleId><ArticleId IdType="pmc">PMC8318721</ArticleId><ArticleId IdType="pubmed">34312316</ArticleId></ArticleIdList></Reference><Reference><Citation>
NHS England and Improvement . Long COVID: the NHS plan for 2021/22, 2021. Available: https://www.england.nhs.uk/coronavirus/publication/long-covid-the-nhs-plan-for-2021-22/ [Accessed 15 Dec 2021].</Citation></Reference><Reference><Citation>Devlin NJ, Brooks R. EQ-5D and the EuroQol group: past, present and future. Appl Health Econ Health Policy 2017;15:127&#x2013;37. 10.1007/s40258-017-0310-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40258-017-0310-5</ArticleId><ArticleId IdType="pmc">PMC5343080</ArticleId><ArticleId IdType="pubmed">28194657</ArticleId></ArticleIdList></Reference><Reference><Citation>
EuroQol Research Foundation . EQ-5D, 2021. Available: https://euroqol.org/ [Accessed 10 Dec 2021].</Citation></Reference><Reference><Citation>Jones P, Harding G, Wiklund I, et al. . Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J 2009;18:208&#x2013;15. 10.4104/pcrj.2009.00053</Citation><ArticleIdList><ArticleId IdType="doi">10.4104/pcrj.2009.00053</ArticleId><ArticleId IdType="pmc">PMC6619275</ArticleId><ArticleId IdType="pubmed">19690787</ArticleId></ArticleIdList></Reference><Reference><Citation>Daynes E, Gerlis C, Briggs-Price S, et al. . Copd assessment test for the evaluation of COVID-19 symptoms. Thorax 2021;76:185&#x2013;7. 10.1136/thoraxjnl-2020-215916</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215916</ArticleId><ArticleId IdType="pubmed">33148809</ArticleId></ArticleIdList></Reference><Reference><Citation>Daynes E, Gerlis C, Chaplin E, et al. . Early experiences of rehabilitation for individuals post-COVID to improve fatigue, breathlessness exercise capacity and cognition - A cohort study. Chron Respir Dis 2021;18:14799731211015691. 10.1177/14799731211015691</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/14799731211015691</ArticleId><ArticleId IdType="pmc">PMC8114752</ArticleId><ArticleId IdType="pubmed">33957805</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanini A, Aiello M, Adamo D, et al. . Estimation of minimal clinically important difference in EQ-5D visual analog scale score after pulmonary rehabilitation in subjects with COPD. Respir Care 2015;60:88&#x2013;95. 10.4187/respcare.03272</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.03272</ArticleId><ArticleId IdType="pubmed">25336531</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae E, Choi S-E, Lee H, et al. . Validity of EQ-5D utility index and minimal clinically important difference estimation among patients with chronic obstructive pulmonary disease. BMC Pulm Med 2020;20:73. 10.1186/s12890-020-1116-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-020-1116-z</ArticleId><ArticleId IdType="pmc">PMC7092534</ArticleId><ArticleId IdType="pubmed">32293387</ArticleId></ArticleIdList></Reference><Reference><Citation>Kon SSC, Canavan JL, Jones SE, et al. . Minimum clinically important difference for the COPD assessment test: a prospective analysis. Lancet Respir Med 2014;2:195&#x2013;203. 10.1016/S2213-2600(14)70001-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(14)70001-3</ArticleId><ArticleId IdType="pubmed">24621681</ArticleId></ArticleIdList></Reference><Reference><Citation>McGregor G, Sandhu H, Bruce J, et al. . Rehabilitation exercise and psycholoGical support after covid-19 infection' (regain): a structured summary of a study protocol for a randomised controlled trial. Trials 2021;22:8. 10.1186/s13063-020-04978-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-020-04978-9</ArticleId><ArticleId IdType="pmc">PMC7785779</ArticleId><ArticleId IdType="pubmed">33407804</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>